These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 37243620)
1. Development of Liu H; Sun Y; Li J; Chen Y; Liu J; Fang J; Yang H; Feng L; Peng S; Zhuang R; Guo Z; Zhang X Mol Pharm; 2023 Jul; 20(7):3529-3538. PubMed ID: 37243620 [TBL] [Abstract][Full Text] [Related]
2. Fang J; Zhang J; Meng L; Li H; Xia D; Wang Y; Chen H; Liao Z; Zhuang R; Li Y; Zhang X; Guo Z Mol Pharm; 2024 Apr; 21(4):1942-1951. PubMed ID: 38447198 [TBL] [Abstract][Full Text] [Related]
3. A novel Fang J; Feng L; Meng L; Wang X; Liu H; Huang L; Zhang D; Li J; Zhuang R; Guo Z; Zhang X Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):27-37. PubMed ID: 36066666 [TBL] [Abstract][Full Text] [Related]
4. Development of STING probes and visualization of STING in multiple tumor types. Liu H; Liu J; Chen Y; Yang H; Fang J; Zeng X; Zhang J; Peng S; Liang Y; Zhuang R; Liu G; Zhang X; Guo Z Eur J Nucl Med Mol Imaging; 2024 Sep; ():. PubMed ID: 39289182 [TBL] [Abstract][Full Text] [Related]
5. STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [ Liang K; Abt ER; Le TM; Cho A; Dann AM; Cui J; Li L; Rashid K; Creech AL; Wei L; Ghukasyan R; Rosser EW; Wu N; Carlucci G; Czernin J; Donahue TR; Radu CG Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480004 [TBL] [Abstract][Full Text] [Related]
6. STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy. Xu D; Lu X; Yang F; Jiang Z; Yang S; Bi L; Liu J; Shan H; Li D Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):641-655. PubMed ID: 37924341 [TBL] [Abstract][Full Text] [Related]
7. Quantitative PET Imaging of Tissue Factor Expression Using 18F-Labeled Active Site-Inhibited Factor VII. Nielsen CH; Erlandsson M; Jeppesen TE; Jensen MM; Kristensen LK; Madsen J; Petersen LC; Kjaer A J Nucl Med; 2016 Jan; 57(1):89-95. PubMed ID: 26383146 [TBL] [Abstract][Full Text] [Related]
8. Preclinical Evaluation of Fang J; Wang X; Meng L; Zhang J; Zhuang R; Li Y; Zhang X; Guo Z ACS Pharmacol Transl Sci; 2024 Jun; 7(6):1783-1794. PubMed ID: 38898942 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085 [TBL] [Abstract][Full Text] [Related]
10. A novel aliphatic 18F-labeled probe for PET imaging of melanoma. Liu H; Liu S; Miao Z; Jiang H; Deng Z; Hong X; Cheng Z Mol Pharm; 2013 Sep; 10(9):3384-91. PubMed ID: 23927458 [TBL] [Abstract][Full Text] [Related]
11. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts. Persson M; Liu H; Madsen J; Cheng Z; Kjaer A Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763 [TBL] [Abstract][Full Text] [Related]
12. A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor. Miao Z; Ren G; Jiang L; Liu H; Webster JM; Zhang R; Namavari M; Gambhir SS; Syud F; Cheng Z Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):1977-84. PubMed ID: 21761266 [TBL] [Abstract][Full Text] [Related]
13. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging. Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309 [TBL] [Abstract][Full Text] [Related]
14. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298 [TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation. Zhou Z; Zalutsky MR; Chitneni SK Mol Pharm; 2021 Oct; 18(10):3871-3881. PubMed ID: 34523337 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors. Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326 [TBL] [Abstract][Full Text] [Related]
17. Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. Cheng Z; De Jesus OP; Namavari M; De A; Levi J; Webster JM; Zhang R; Lee B; Syud FA; Gambhir SS J Nucl Med; 2008 May; 49(5):804-13. PubMed ID: 18413392 [TBL] [Abstract][Full Text] [Related]
18. A new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors. Ross TL; Honer M; Müller C; Groehn V; Schibli R; Ametamey SM J Nucl Med; 2010 Nov; 51(11):1756-62. PubMed ID: 20956469 [TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
20. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma. Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]